Creating Microbiome Biotherapeutics
At Quorum Innovations, we believe the future of medicine begins within. The human body is host to a vast, dynamic ecosystem—the humanmicrobiome—that outnumbers human cells ten to one. While the human genome contains about 23,000 genes, the microbiome brings over 3.5 million genes to the table. This immense genetic reservoirsupports not only core physiological functions but also criticalbiological defenses—including protection against environmentaltoxins, chemical threats, and microbial invaders. It represents atransformative frontier for advancing human health and resilience.
Our Research
Quorum has developed a robust and diversified portfolio of active microbiome biotherapeutics through the real-world application of translational science. By combining early insight into the broad clinical potential of the human microbiome with a disciplined translationalapproach, Quorum has advanced multiple Probiomic™ biotherapeutics candidates and secured an intellectual property estate of more than 50 patents. This integrated strategy positions Quorum at the forefront of next-generation microbiome biotherapeutics.